Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+20.2%
5Y CAGR+31.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+20.2%/yr
vs +73.9%/yr prior
5Y CAGR
+31.8%/yr
Recent deceleration
Acceleration
-53.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $202.97M | +47.2% |
| 2024 | $137.93M | +11.6% |
| 2023 | $123.55M | +5.8% |
| 2022 | $116.76M | +35.7% |
| 2021 | $86.06M | +68.4% |
| 2020 | $51.12M | +45.1% |
| 2019 | $35.23M | +175.6% |
| 2018 | $12.78M | +130.1% |
| 2017 | $5.55M | - |